Bilibili Inc. (NASDAQ: BILI): BofA Securities raised its Neutral rating to Buy with a $28 target price. The consensus target is $27.30. Monday’s $21.10 close was up almost 7% for the day on the upgrade.
Bill Holdings Inc. (NYSE: BILL): Jefferies reiterated a Buy rating with a $125 target price. The consensus target is higher at $139.86, but the stock closed on Monday at $73.82. That was up 8% on the day, after the company’s exposure to bank issues in California were seen as not a problem.
Cabot Corp. (NYSE: CBT): Credit Suisse initiated coverage with an Outperform rating and a $94 target price. The consensus target is $92.80, and the stock closed on Monday at $73.59.
Coinbase Global Inc. (NASDAQ: COIN): Though Oppenheimer maintained an Outperform rating, the firm lowered its $84 target price to $70. The shares traded near $185 a year ago but closed most recently at $59.17. That was a one-day gain of 11% due to the surge in Bitcoin on Monday.
Eli Lilly and Co. (NYSE: LLY): When Wells Fargo lifted its Equal Weight rating to Overweight, it also raised its $360 target price to $375. The consensus target is $380.13. The shares closed up 3% on Monday at $324.49.
GE Healthcare Technologies Inc. (NASDAQ: GEHC): Evercore ISI initiated coverage with an Outperform rating and a $90 target price, the same as the consensus target. The shares finished Monday at $76.24.
Genius Sports Ltd. (NASDAQ: GENI): Oppenheimer maintained an Outperform rating with a $7 target price. The consensus target is $7.50, and the shares closed on Monday at $4.24.
Hercules Capital Inc. (NYSE: HTGC): Keefe Bruyette’s downgrade to Underperform from Market Perform included a target price cut to $10.50 from $14.50. The consensus target is $16.22 for now. Monday’s close at $11.56 was down 6% for the day on the downgrade and capital concerns.
Intuit Inc. (NASDAQ: INTU): Oppenheimer reiterated an Outperform. Its $476 price target is less than the $483.95 consensus target. Monday’s closing print was $391.56.
JPMorgan Chase & Co. (NYSE: JPM): Wells Fargo upgraded the shares to Overweight from Equal Weight. Its $148 target price increased to $155, but that is still less than the $158.37 consensus target. The stock closed on Monday at $131.25.
Merck & Co. Inc. (NYSE: MRK): The Overweight rating at Wells Fargo was cut to Equal Weight, and the $120 target price dropped to $115. That compares with a $119.75 target and Monday’s $105.73 closing share price.
Moderna Inc. (NASDAQ: MRNA): TD Cowen’s upgrade to Outperform from Market Perform came with a target price hike to $180 from $150. The consensus target is up at $224.50. The stock closed 7% higher on Monday at $147.90.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
